Redox proteins as targets for drugs development against pathogens

Current Pharmaceutical Design

Volumn 19, Issue 14, 2013, Pages 2594-2605

  Catalano Dupuy, Daniela L ^a   López Rivero, Arleth ^a   Soldano, Anabel ^a   Ceccarelli, Eduardo A ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Drug targets; Ferredoxin; Ferredoxin NADP(H) reductase; Heme oxygenase; Iron sulfur clusters; Iron sulfur proteins; Isoprenoids biosynthesis; Pathogenicity

Indexed keywords

ABC TRANSPORTER; ACETALDEHYDE; ANTIINFECTIVE AGENT; CARBONYL DERIVATIVE; CYTIDINE TRIPHOSPHATE; FERREDOXIN; HEME; HEME OXYGENASE; ISOPRENOID; MEVALONIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PYRUVIC ACID; SULFUR;

ANTIBIOTIC RESISTANCE; APICOMPLEXA; BIOSYNTHESIS; CORYNEBACTERIUM DIPHTHERIAE; DECARBOXYLATION; DRUG DEVELOPMENT; DRUG TARGETING; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME STRUCTURE; GRAM NEGATIVE BACTERIUM; IRON METABOLISM; METABOLISM; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENICITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; REVIEW; SHIGELLA DYSENTERIAE; STAPHYLOCOCCUS AUREUS; TOXOPLASMA GONDII; VIBRIO CHOLERAE; YERSINIA ENTEROCOLITICA;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; COMMUNICABLE DISEASES; DRUG DISCOVERY; HEME OXYGENASE (DECYCLIZING); HUMANS; IRON; IRON-SULFUR PROTEINS; METABOLIC NETWORKS AND PATHWAYS; OXIDATION-REDUCTION; PROTOZOAN PROTEINS; TERPENES;

EID: 84877797113     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319140009     Document Type: Review

References (163)

1. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64 Suppl 1: i3-10.
2. Molbak K. Spread of resistant bacteria and resistance genes from animals to humans--the public health consequences. J Vet Med B Infect Dis Vet Public Health 2004; 51: 364-9.
3. Walsh C. Where will new antibiotics come from? Nat Rev Microbiol 2003; 1: 65-70.
4. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
5. Gootz TD. The global problem of antibiotic resistance. Crit Rev Immunol 2010; 30: 79-93.
6. Carlet J, Jarlier V, Harbarth S, et al. Ready for a world without antibiotics? The Pensieres Antibiotic Resistance Call to Action. Antimicrobial Resistance and Infection Control 2012; 1: 11.
7. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008; 2: e300.
8. Bush K, Courvalin P, Dantas G, et al. Tackling antibiotic resistance. Nat Rev Microbiol 2011; 9: 894-6.
9. Chen Y, Hu L. Design of anticancer prodrugs for reductive activation. Med Res Rev 2009; 29: 29-64.
10. Graf N, Lippard SJ. Redox activation of metal-based prodrugs as a strategy for drug delivery. Adv Drug Deliv Rev 2012.
11. Strolin Benedetti M. FAD-dependent enzymes involved in the metabolic oxidation of xenobiotics. Ann Pharm Fr 2011; 45-51.
12. Albesa I, Becerra MC, Battan PC, Paez PL. Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun 2004; 317: 605-9.
13. Wanke M, Skorupinska-Tudek K, Swiezewska E. Isoprenoid biosynthesis via 1-deoxy-D-xylulose 5-phosphate/2-C-methyl-Derythritol 4-phosphate (DOXP/MEP) pathway. Acta Biochim Pol 2001; 48: 663-72.
14. Langenheim JH. Higher plant terpenoids: a phytocentric overview of their ecological roles. J Chem Ecol 1994; 20: 1223-1280.
15. Duke, Dayan, Romagni, Rimando Natural products as sources of herbicides: current status and future trends. Weed Research 2000; 40: 99-111.
16. Sacchettini JC, Poulter CD Creating isoprenoid diversity. Science 1997; 277: 1788-9.
17. Bach TJ, Boronat A, Campos N, Ferrer A, Vollack KU. Mevalonate biosynthesis in plants. Crit Rev Biochem Mol Biol 1999; 34: 107-22.
18. Rohmer M, Knani M, Simonin P, Sutter B, Sahm H Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem J 1993; 295 (Pt 2): 517-24.
19. Schwender J, Seemann M, Lichtenthaler HK, Rohmer M. Biosynthesis of isoprenoids (carotenoids, sterols, prenyl side-chains of chlorophylls and plastoquinone) via a novel pyruvate/ glyceraldehyde 3-phosphate non-mevalonate pathway in the green alga Scenedesmus obliquus. Biochem J 1996; 316 (Pt 1): 73-80.
20. Lichtenthaler HK, Schwender J, Disch A, Rohmer M. Biosynthesis of isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway. FEBS Lett 1997; 400: 271-4.
21. Schwender J, Zeidler J, Groner R, et al. Incorporation of 1-deoxy-D-xylulose into isoprene and phytol by higher plants and algae. FEBS Lett 1997; 414: 129-34.
22. Catalano-Dupuy DL, Ceccarelli EA. Searching for the role of the plastidic-type Ferredoxin-NADP(H) reductase in Leptospira interrogans. In: Frago S, Gomez-Moreno C, Medina M, editors. Flavins and Flavoproteins. Prensas Universitarias de Zaragoza. 2008; pp. 249-54.
23. Catalano-Dupuy DL, Musumeci MA, Lopez-Rivero A, Ceccarelli EA. A highly stable plastidic-type ferredoxin-NADP(H) reductase in the pathogenic bacterium Leptospira interrogans. PLoS One 2011; 6: e26736.
24. Arigoni D, Sagner S, Latzel C, et al. Terpenoid biosynthesis from 1-deoxy-D-xylulose in higher plants by intramolecular skeletal rearrangement. Proc Natl Acad Sci USA 1997; 94: 10600-5.
25. Ostrovsky D, Diomina G, Lysak E, et al. Effect of oxidative stress on the biosynthesis of 2-C-methyl-D-erythritol-2,4-cyclopyrophosphate and isoprenoids by several bacterial strains. Arch Microbiol 1998; 171: 69-72.
26. Altincicek B, Duin EC, Reichenberg A, et al. LytB protein catalyzes the terminal step of the 2-C-methyl-D-erythritol-4-phosphate pathway of isoprenoid biosynthesis. FEBS Lett 2002; 532: 437-40.
27. Kollas AK, Duin EC, Eberl M, et al. Functional characterization of GcpE, an essential enzyme of the non-mevalonate pathway of isoprenoid biosynthesis. FEBS Lett 2002; 532: 432-6.
28. Wolff M, Seemann M, Tse Sum BB, et al. Isoprenoid biosynthesis via the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (LytB/IspH) from Escherichia coli is a [4Fe-4S] protein. FEBS Lett 2003; 541: 115-20.
29. Grawert T, Groll M, Rohdich F, Bacher A, Eisenreich W. Biochemistry of the non-mevalonate isoprenoid pathway. Cell Mol Life Sci 2011; 68: 3797-814.
30. Seemann M, Bui BT, Wolff M, et al. Isoprenoid biosynthesis through the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE) is a [4Fe-4S] protein. Angew Chem Int Ed Engl 2002; 41: 4337-9.
31. Okada K, Hase T. Cyanobacterial non-mevalonate pathway: (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase interacts with ferredoxin in Thermosynechococcus elongatus BP-1. J Biol Chem 2005; 280: 20672-79.
32. + reductase/ferredoxin redox system as a possible drug target against apicomplexan human parasites. Curr Pharm Des 2005; 11: 3159-72.
33. Wiesner J, Jomaa H. Isoprenoid biosynthesis of the apicoplast as drug target. Curr Drug Targets 2007; 8: 3-13.
34. Disch A, Hemmerlin A, Bach TJ, Rohmer M. Mevalonate-derived isopentenyl diphosphate is the biosynthetic precursor of ubiquinone prenyl side chain in tobacco BY-2 cells. Biochem J 1998; 331 (Pt 2): 615-21.
35. Cvejic JH, Rohmer M. CO2 as main carbon source for isoprenoid biosynthesis via the mevalonate-independent methylerythritol 4-phosphate route in the marine diatoms Phaeodactylum tricornutum and Nitzschia ovalis. Phytochemistry 2000; 53: 21-8.
36. Eberl M, Hintz M, Reichenberg A, et al. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 2003; 544: 4-10.
37. Zeidler JG, Lichtenthaler HK, May HU, Lichtenthaler FW. Is isoprene emitted by plants synthesized via the novel isopentenyl pyrophosphate pathway? Z Naturforsch 1997; 52: 15-23.
38. Lichtenthaler HK, Rohmer M, Schwender J. Two independent biochemical pathways for isopentenyl diphosphate and isoprenoid biosynthesis in higher plants. Physiologia Plantarum 1997; 101: 643-52.
39. Eisenreich W, Schwarz M, Cartayrade A, et al. The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chem Biol 1998; 5: R221-33.
40. Rohmer M. The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants. Nat Prod Rep 1999; 16: 565-74.
41. Eisenreich W, Rohdich F, Bacher A. Deoxyxylulose phosphate pathway to terpenoids. Trends Plant Sci 2001; 6: 78-84.
42. Rodriguez-Concepcion M, Boronat A. Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics. Plant Physiol 2002; 130: 1079-89.
43. Lange BM, Rujan T, Martin W, Croteau R. Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proc Natl Acad Sci USA 2000; 97: 13172-7.
44. Hoeffler JF, Hemmerlin A, Grosdemange-Billiard C, Bach TJ, Rohmer M. Isoprenoid biosynthesis in higher plants and in Escherichia coli: on the branching in the methylerythritol phosphate pathway and the independent biosynthesis of isopentenyl diphosphate and dimethylallyl diphosphate. Biochem J 2002; 366: 573-83.
45. Querol J, Campos N, Imperial S, Boronat A, Rodriguez-Concepcion M. Functional analysis of the Arabidopsis thaliana GCPE protein involved in plastid isoprenoid biosynthesis. FEBS Lett 2002; 514: 343-6.
46. Wiesner J, Borrmann S, Jomaa H Fosmidomycin for the treatment of malaria. Parasitol Res 2003; 90 Suppl 2: S71-6.
47. Rohmer M, Grosdemange-Billiard C, Seemann M, Tritsch D. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs. Curr Opin Investig Drugs 2004; 5: 154-62.
48. Wiesner J, Seeber F. The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugs. Expert Opin Ther Targets 2005; 9: 23-44.
49. Kuzuyama T, Shimizu T, Takahashi S, Seto H. Fosmidomycin, a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis. Tetrahedron Letters 1998; 39: 7913-6.
50. Missinou MA, Borrmann S, Schindler A, et al. Fosmidomycin for malaria. Lancet 2002; 360: 1941-2.
51. Rohrich RC, Englert N, Troschke K, et al. Reconstitution of an apicoplast-localised electron transfer pathway involved in the isoprenoid biosynthesis of Plasmodium falciparum. FEBS Lett 2005; 579: 6433-8.
52. Singh N, Cheve G, Avery MA, McCurdy CR. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme. Curr Pharm Des 2007; 13: 1161-77.
53. Andrews SC, Robinson AK, Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 2003; 27: 215-37.
54. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and disease. Mol Aspects Med 2001; 22: 1-87.
55. Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity: Heme oxygenase has both pro-and antioxidant properties. Free Radical Biology and Medicine 2000; 28: 289-309.
56. Tong Y, Guo M. Bacterial heme-transport proteins and their hemecoordination modes. Arch Biochem Biophys 2009; 481: 1-15.
57. Bothwell TH. Overview and mechanisms of iron regulation. Nutr Rev 1995; 53: 237-45.
58. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol 2006; 55: 251-8.
59. Wandersman C, Stojiljkovic I. Bacterial heme sources: the role of heme, hemoprotein receptors and hemophores. Curr Opin Microbiol 2000; 3: 215-20.
60. Anzaldi LL, Skaar EP. Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens. Infect Immun 2010; 78: 4977-89.
61. Ochsner UA, Johnson Z, Vasil ML. Genetics and regulation of two distinct haem-uptake systems, phu and has, in Pseudomonas aeruginosa. Microbiology 2000; 146 (Pt 1): 185-98.
62. Henderson DP, Payne SM. Vibrio cholerae iron transport systems: roles of heme and siderophore iron transport in virulence and identification of a gene associated with multiple iron transport systems. Infect Immun 1994; 62: 5120-5.
63. Stojiljkovic I, Hantke K. Hemin uptake system of Yersinia enterocolitica: similarities with other TonB-dependent systems in gram-negative bacteria. EMBO J 1992; 11: 4359-67.
64. Mills M, Payne SM. Genetics and regulation of heme iron transport in Shigella dysenteriae and detection of an analogous system in Escherichia coli O157:H7. J Bacteriol 1995; 177: 3004-9.
65. Ghigo JM, Letoffe S, Wandersman C. A new type of hemophoredependent heme acquisition system of Serratia marcescens reconstituted in Escherichia coli. J Bacteriol 1997; 179: 3572-9.
66. Maciver I, Latimer JL, Liem HH, et al. Identification of an outer membrane protein involved in utilization of hemoglobinhaptoglobin complexes by nontypeable Haemophilus influenzae. Infect Immun 1996; 64: 3703-12.
67. Lewis LA, Gray E, Wang YP, Roe BA, Dyer DW. Molecular characterization of hpuAB, the haemoglobin-haptoglobinutilization operon of Neisseria meningitidis. Mol Microbiol 1997; 23: 737-49.
68. Schryvers AB, Stojiljkovic I. Iron acquisition systems in the pathogenic Neisseria. Mol Microbiol 1999; 32: 1117-1123.
69. Rohde KH, Gillaspy AF, Hatfield MD, Lewis LA, Dyer DW. Interactions of haemoglobin with the Neisseria meningitidis receptor HpuAB: the role of TonB and an intact proton motive force. Mol Microbiol 2002; 43: 335-54.
70. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. Ironsource preference of Staphylococcus aureus infections. Science 2004; 305: 1626-8.
71. Schmitt MP. Utilization of host iron sources by Corynebacterium diphtheriae: identification of a gene whose product is homologous to eukaryotic heme oxygenases and is required for acquisition of iron from heme and hemoglobin. J Bacteriol 1997; 179: 838-45.
72. Drazek ES, Hammack CA, Schmitt MP. Corynebacterium diphtheriae genes required for acquisition of iron from haemin and haemoglobin are homologous to ABC haemin transporters. Mol Microbiol 2000; 36: 68-84.
73. Francis RT, Jr., Booth JW, Becker RR Uptake of iron from hemoglobin and the haptoglobin-hemoglobin complex by hemolytic bacteria. Int J Biochem 1985; 17: 767-73.
74. Bates CS, Montanez GE, Woods CR, Vincent RM, Eichenbaum Z. Identification and characterization of a Streptococcus pyogenes operon involved in binding of hemoproteins and acquisition of iron. Infect Immun 2003; 71: 1042-55.
75. Fabian M, Solomaha E, Olson JS, Maresso AW. Heme transfer to the bacterial cell envelope occurs via a secreted hemophore in the Gram-positive pathogen Bacillus anthracis. J Biol Chem 2009; 284: 32138-46.
76. Murray GL, Ellis KM, Lo M, Adler B. Leptospira interrogans requires a functional heme oxygenase to scavenge iron from hemoglobin. Microbes Infect 2008; 10: 791-7.
77. Yuri K, Takamoto Y, Okada M, et al. Chemotaxis of leptospires to hemoglobin in relation to virulence. Infect Immun 1993; 61: 2270-2272.
78. Louvel H, Bommezzadri S, Zidane N, et al. Comparative and functional genomic analyses of iron transport and regulation in Leptospira spp. J Bacteriol 2006; 188: 7893-904.
79. Li C, Stocker R. Heme oxygenase and iron: from bacteria to humans. Redox Rep 2009; 14: 95-101.
80. Yoshida T, Kikuchi G. Features of the reaction of heme degradation catalyzed by the reconstituted microsomal heme oxygenase system. J Biol Chem 1978; 253: 4230-6.
81. Ortiz de Montellano PR, Wilks A. Heme oxygenase structure and mechanism. Adv Inorg Chem 2001; 51: 359-407.
82. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969; 244: 6388-94.
83. Davis SJ, Bhoo SH, Durski AM, Walker JM, Vierstra RD. The heme-oxygenase family required for phytochrome chromophore biosynthesis is necessary for proper photomorphogenesis in higher plants. Plant Physiol 2001; 126: 656-69.
84. Beale SI, Cornejo J. Enzymatic heme oxygenase activity in soluble extracts of the unicellular red alga, Cyanidium caldarium. Arch Biochem Biophys 1984; 235: 371-84.
85. Richaud C, Zabulon G. The heme oxygenase gene (pbsA) in the red alga Rhodella violacea is discontinuous and transcriptionally activated during iron limitation. Proc Natl Acad Sci USA 1997; 94: 11736-41.
86. Cornejo J, Willows RD, Beale SI. Phytobilin biosynthesis: cloning and expression of a gene encoding soluble ferredoxin-dependent heme oxygenase from Synechocystis sp. PCC 6803. Plant J 1998; 15: 99-107.
87. Pendrak ML, Chao MP, Yan SS, Roberts DD. Heme oxygenase in Candida albicans is regulated by hemoglobin and is necessary for metabolism of exogenous heme and hemoglobin to alphabiliverdin. J Biol Chem 2004; 279: 3426-33.
88. Kim D, Yukl ET, Moenne-Loccoz P, Montellano PR. Fungal heme oxygenases: Functional expression and characterization of Hmx1 from Saccharomyces cerevisiae and CaHmx1 from Candida albicans. Biochemistry 2006; 45: 14772-80.
89. Wilks A, Schmitt MP. Expression and characterization of a heme oxygenase (Hmu O) from Corynebacterium diphtheriae. Iron acquisition requires oxidative cleavage of the heme macrocycle. J Biol Chem 1998; 273: 837-41.
90. Zhu W, Hunt DJ, Richardson AR, Stojiljkovic I. Use of heme compounds as iron sources by pathogenic neisseriae requires the product of the hemO gene. J Bacteriol 2000; 182: 439-47.
91. Ratliff M, Zhu W, Deshmukh R, Wilks A, Stojiljkovic I. Homologues of neisserial heme oxygenase in gram-negative bacteria: degradation of heme by the product of the pigA gene of Pseudomonas aeruginosa. J Bacteriol 2001; 183: 6394-403.
92. Okada K The novel heme oxygenase-like protein from Plasmodium falciparum converts heme to bilirubin IX alpha in the apicoplast. FEBS Lett 2009; 583: 313-9.
93. Schuller DJ, Wilks A, Ortiz De Montellano PR, Poulos TL. Crystal structure of human heme oxygenase-1. Nat Struct Biol 1999; 6: 860-7.
94. Sugishima M, Omata Y, Kakuta Y, et al. Crystal structure of rat heme oxygenase-1 in complex with heme. FEBS Lett 2000; 471: 61-6.
95. Schuller DJ, Zhu W, Stojiljkovic I, Wilks A, Poulos TL. Crystal structure of heme oxygenase from the gram-negative pathogen Neisseria meningitidis and a comparison with mammalian heme oxygenase-1. Biochemistry 2001; 40: 11552-8.
96. Hirotsu S, Chu GC, Unno M, et al. The crystal structures of the ferric and ferrous forms of the heme complex of HmuO, a heme oxygenase of Corynebacterium diphtheriae. J Biol Chem 2004; 279: 11937-47.
97. Friedman J, Lad L, Li H, Wilks A, Poulos TL. Structural basis for novel delta-regioselective heme oxygenation in the opportunistic pathogen Pseudomonas aeruginosa. Biochemistry 2004; 43: 5239-45.
98. Sugishima M, Migita CT, Zhang X, Yoshida T, Fukuyama K. Crystal structure of heme oxygenase-1 from cyanobacterium Synechocystis sp. PCC 6803 in complex with heme. Eur J Biochem 2004; 271: 4517-25.
99. Sugishima M, Hagiwara Y, Zhang X, et al. Crystal structure of dimeric heme oxygenase-2 from Synechocystis sp. PCC 6803 in complex with heme. Biochemistry 2005; 44: 4257-66.
100. Zhang R, Zhang J, Guo G, et al. Crystal structure of Campylobacter jejuni ChuZ: a split-barrel family heme oxygenase with a novel heme-binding mode. Biochem Biophys Res Commun 2011; 415: 82-7.
101. Hu Y, Jiang F, Guo Y, et al. Crystal structure of HugZ, a novel heme oxygenase from Helicobacter pylori. J Biol Chem 2011; 286: 1537-44.
102. Rahman MN, Vlahakis JZ, Vukomanovic D, et al. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[(5-trifluorom ethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode. J Med Chem 2009; 52: 4946-50.
103. Rahman MN, Vlahakis JZ, Vukomanovic D, et al. A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition. PLoS One 2012; 7: e29514.
104. Unno M, Matsui T, Ikeda-Saito M. Structure and catalytic mechanism of heme oxygenase. Nat Prod Rep 2007; 24: 553-70.
105. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem 1986; 261: 411-9.
106. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-54.
107. Migita CT, Zhang X, Yoshida T. Expression and characterization of cyanobacterium heme oxygenase, a key enzyme in the phycobilin synthesis. Properties of the heme complex of recombinant active enzyme. Eur J Biochem 2003; 270: 687-98.
108. Muramoto T, Tsurui N, Terry MJ, Yokota A, Kohchi T. Expression and biochemical properties of a ferredoxin-dependent heme oxygenase required for phytochrome chromophore synthesis. Plant Physiol 2002; 130: 1958-66.
109. Davis SJ, Kurepa J, Vierstra RD. The Arabidopsis thaliana HY1 locus, required for phytochrome-chromophore biosynthesis, encodes a protein related to heme oxygenases. Proc Natl Acad Sci USA 1999; 96: 6541-6.
110. Frankenberg-Dinkel N. Bacterial heme oxygenases. Antioxid Redox Signal 2004; 6: 825-34.
111. Yoshida T, Noguchi M, Kikuchi G. Oxygenated form of heme. heme oxygenase complex and requirement for second electron to initiate heme degradation from the oxygenated complex. J Biol Chem 1980; 255: 4418-20.
112. Wilks A, Torpey J, Ortiz De Montellano PR. Heme oxygenase (HO-1). Evidence for electrophilic oxygen addition to the porphyrin ring in the formation of alpha-meso-hydroxyheme. J Biol Chem 1994; 269: 29553-6.
113. Matsui T, Unno M, Ikeda-Saito M. Heme oxygenase reveals its strategy for catalyzing three successive oxygenation reactions. Acc Chem Res 2010; 43: 240-7.
114. Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochem Biophys Res Commun 2005; 338: 558-67.
115. Yoshida T, Kikuchi G. Reaction of the microsomal heme oxygenase with cobaltic protoporphyrin IX, and extremely poor substrate. J Biol Chem 1978; 253: 8479-82.
116. Liu Y, Ortiz De Montellano PR. Reaction intermediates and single turnover rate constants for the oxidation of heme by human heme oxygenase-1. J Biol Chem 2000; 275: 5297-307.
117. Caignan GA, Deshmukh R, Wilks A, et al. Oxidation of heme to beta-and delta-biliverdin by Pseudomonas aeruginosa heme oxygenase as a consequence of an unusual seating of the heme. J Am Chem Soc 2002; 124: 14879-92.
118. Schacter BA, Nelson EB, Marver HS, Masters BS. Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J Biol Chem 1972; 247: 3601-7.
119. Gohya T, Zhang X, Yoshida T, Migita CT. Spectroscopic characterization of a higher plant heme oxygenase isoform-1 from Glycine max (soybean)--coordination structure of the heme complex and catabolism of heme. FEBS J 2006; 273: 5384-99.
120. Wegele R, Tasler R, Zeng Y, Rivera M, Frankenberg-Dinkel N. The heme oxygenase(s)-phytochrome system of Pseudomonas aeruginosa. J Biol Chem 2004; 279: 45791-802.
121. + reductase and not ferredoxin is the redox partner of heme oxygenase under iron-starvation conditions. Biochemistry 2007; 46: 12198-211.
122. Ballouche M, Cornelis P, Baysse C. Iron metabolism: a promising target for antibacterial strategies. Recent Pat Antiinfect Drug Discov 2009; 4: 190-205.
123. Murray GL, Srikram A, Henry R, et al. Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes Infect 2009; 11: 311-4.
124. Furci LM, Lopes P, Eakanunkul S, et al. Inhibition of the bacterial heme oxygenases from Pseudomonas aeruginosa and Neisseria meningitidis: novel antimicrobial targets. J Med Chem 2007; 50: 3804-13.
125. Evans JP, Kandel S, Ortiz De Montellano PR. Isocyanides inhibit human heme oxygenases at the verdoheme stage. Biochemistry 2009; 48: 8920-8.
126. Rahman MN, Vlahakis JZ, Roman G, et al. Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors. J Inorg Biochem 2010; 104: 324-30.
127. Kinobe RT, Vlahakis JZ, Vreman HJ, et al. Selectivity of imidazole-dioxolane compounds for in vitro inhibition of microsomal haem oxygenase isoforms. Br J Pharmacol 2006; 147: 307-15.
128. Beinert H, Holm RH, Munck E. Iron-sulfur clusters: nature's modular, multipurpose structures. Science 1997; 277: 653-9.
129. Sheftel A, Stehling O, Lill R. Iron-sulfur proteins in health and disease. Trends Endocrinol Metab 2010.
130. Rouault TA, Tong WH. Iron-sulfur cluster biogenesis and human disease. Trends Genet 2008; 24: 398-407.
131. Fontecave M, Ollagnier-de-Choudens S. Iron-sulfur cluster biosynthesis in bacteria: Mechanisms of cluster assembly and transfer. Arch Biochem Biophys 2008; 474: 226-37.
132. Vinella D, Brochier-Armanet C, Loiseau L, Talla E, Barras F. Ironsulfur (Fe/S) protein biogenesis: phylogenomic and genetic studies of A-type carriers. PLoS Genet 2009; 5: e1000497.
133. Ayala-Castro C, Saini A, Outten FW. Fe-S cluster assembly pathways in bacteria. Microbiol Mol Biol Rev 2008; 72: 110-25.
134. Johnson DC, Dos Santos PC, Dean DR. NifU and NifS are required for the maturation of nitrogenase and cannot replace the function of isc-gene products in Azotobacter vinelandii. Biochem Soc Trans 2005; 33: 90-93.
135. Johnson DC, Dean DR, Smith AD, Johnson MK. Structure, function, and formation of biological iron-sulfur clusters. Annu Rev Biochem 2005; 74: 247-81.
136. Outten FW, Wood MJ, Munoz FM, Storz G. The SufE protein and the SufBCD complex enhance SufS cysteine desulfurase activity as part of a sulfur transfer pathway for Fe-S cluster assembly in Escherichia coli. J Biol Chem 2003; 278: 45713-9.
137. Nachin L, Loiseau L, Expert D, Barras F. SufC: an unorthodox cytoplasmic ABC/ATPase required for [Fe-S] biogenesis under oxidative stress. EMBO J 2003; 22: 427-37.
138. Giel JL, Rodionov D, Liu M, Blattner FR, Kiley PJ. IscRdependent gene expression links iron-sulphur cluster assembly to the control of O2-regulated genes in Escherichia coli. Mol Microbiol 2006; 60: 1058-75.
139. Schwartz CJ, Giel JL, Patschkowski T, et al. IscR, an Fe-S clustercontaining transcription factor, represses expression of Escherichia coli genes encoding Fe-S cluster assembly proteins. Proc Natl Acad Sci USA 2001; 98: 14895-900.
140. Barras F, Loiseau L, Py B. How Escherichia coli and Saccharomyces cerevisiae build Fe/S proteins. Adv Microb Physiol 2005; 50: 41-101.
141. Albrecht AG, Netz DJ, Miethke M, et al. SufU is an essential ironsulfur cluster scaffold protein in Bacillus subtilis. J Bacteriol 2010.
142. Lill R. Function and biogenesis of iron-sulphur proteins. Nature 2009; 460: 831-8.
143. Bhave DP, Muse WB, III, Carroll KS. Drug targets in mycobacterial sulfur metabolism. Infect Disord Drug Targets 2007; 7: 140-58.
144. Zuris JA, Harir Y, Conlan AR, et al. Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc Natl Acad Sci USA 2011; 108: 13047-52.
145. Mietzner TA, Morse SA. The role of iron-binding proteins in the survival of pathogenic bacteria. Annu Rev Nutr 1994; 14: 471-93.
146. Olson JW, Agar JN, Johnson MK, Maier RJ. Characterization of the NifU and NifS Fe-S cluster formation proteins essential for viability in Helicobacter pylori. Biochemistry 2000; 39: 16213-9.
147. Moura JJ, Moura I, Kent TA, et al. Interconversions of [3Fe-3S] and [4Fe-4S] clusters. Mossbauer and electron paramagnetic resonance studies of Desulfovibrio gigas ferredoxin II. J Biol Chem 1982; 257: 6259-67.
148. Krapp AR, Humbert MV, Carrillo N. The soxRS response of Escherichia coli can be induced in the absence of oxidative stress and oxygen by modulation of NADPH content. Microbiology 2011; 157: 957-65.
149. + oxidoreductase. In The Light Reactions. In: Barber J, editors. Topics in Photosynthesis. Amsterdam-New York-Oxford: Elsevier.1987; pp. 527-60.
150. Giro M, Carrillo N, Krapp AR. Glucose-6-phosphate dehydrogenase and ferredoxin-NADP(H) reductase contribute to damage repair during the soxRS response of Escherichia coli. Microbiology 2006; 152: 1119-28.
151. Elsen S, Efthymiou G, Peteinatos P, et al. A bacteria-specific 2[4Fe-4S] ferredoxin is essential in Pseudomonas aeruginosa. BMC Microbiol 2010; 10: 271.
152. Huet G, Daffe M, Saves I. Identification of the Mycobacterium tuberculosis SUF machinery as the exclusive mycobacterial system of [Fe-S] cluster assembly: evidence for its implication in the pathogen's survival. J Bacteriol 2005; 187: 6137-46.
153. Runyen-Janecky L, Daugherty A, Lloyd B, et al. Role and regulation of iron-sulfur cluster biosynthesis genes in Shigella flexneri virulence. Infect Immun 2008; 76: 1083-92.
154. Hanukoglu I, Gutfinger T. cDNA sequence of adrenodoxin reductase. Identification of NADP-binding sites in oxidoreductases. Eur J Biochem 1989; 180: 479-84.
155. + and NADPH suggesting a mechanism for the electron transfer of an enzyme family. Biochemistry 2000; 39: 10986-95.
156. + reductase revealed by protein engineering and crystallographic studies. Nat Struct Biol 1999; 6: 847-53.
157. + reductase catalytic mechanism. Eur J Biochem 2003; 270: 1900-15.
158. Aliverti A, Pandini V, Pennati A, de Rosa M, Zanetti G Structural and functional diversity of ferredoxin-NADP(+) reductases. Arch Biochem Biophys 2008; 474: 283-91.
159. + Reductase with Its Substrates: Optimal Interaction for Efficient Electron Transfer. Photosynth Res 2004; 79: 113-31.
160. Seeber F. Biosynthetic pathways of plastid-derived organelles as potential drug targets against parasitic apicomplexa. Curr Drug Targets Immune Endocr Metabol Disord 2003; 3: 99-109.
161. Seeber F. Malaria and anti-malarials-a focused view. In: P. Selzer, editors. Antiparasitic and Antibacterial Drug Discovery in Infectious Diseases-From Molecular Targets to Drug Candidates. Wiley-VCH, Weinheim. 2009; pp. 277-298.
162. Wang K, Wang W, No JH, et al. Inhibition of the Fe(4)S(4)-cluster-containing protein IspH (LytB): electron paramagnetic resonance, metallacycles, and mechanisms. J Am Chem Soc 2010; 132: 6719-27.
163. Wang W, Li J, Wang K, Smirnova TI, Oldfield E. Pyridine inhibitor binding to the 4Fe-4S protein A. aeolicus IspH (LytB): a HYSCORE Investigation. J Am Chem Soc 2011; 133: 6525-8.